Watch for Jorveza, a New Med for Eosinophilic Esophagitis

Jorveza (budesonide) orodispersible tabs will be the first treatment approved for eosinophilic esophagitis (EoE).

This is a chronic allergic condition in kids and adults that causes inflammation along the esophagus. It can result in symptoms such as trouble swallowing, chest pain, and vomiting.

Patients with EoE often get an inhaled steroid (Flovent HFA, etc) with directions to SWALLOW each puff, instead of inhale...or to mix contents of a steroid nebule into a slurry and swallow.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote